Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
22:30
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

54th ERA-EDTA Congress

 

3rd-6th June 2017 Madrid
FAQs
   
Discussion forum - 54th ERA-EDTA Congress
    Topic - Clinical nephrology II

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 146
Visits: 10
Title: CLINICAL PROFILE AND IMMEDIATE MANAGEMENT OUTCOME OF EMPHYSEMATOUS AND NON-EMPHYSEMATOUS PYELONEPHRITIS IN PATIENTS WITH DIABETES MELLITUS
Authors: Tabassum Samad , Tabassum Samad, Wasim M.M. Haque, Muhammad A. Rahim, Shudhanshu K. Shaha, Mehruba A. Ananna, Tufael A. Choudhury, Sarwar Iqbal
Centre: BIRDEM General Hospital

You must be registered to reply or comment.

CLINICAL PROFILE AND IMMEDIATE MANAGEMENT OUTCOME OF EMPHYSEMATOUS AND NON-EMPHYSEMATOUS PYELONEPHRITIS IN PATIENTS WITH DIABETES MELLITUS

Tabassum Samad
Thread initiator
Subspeciality
Reg: 5/24/2017 9:48:00 PM
Comment# 1
Non-emphysematous/acute pyelonephritis (APN) and emphysematous pyelonephritis (EPN) are potentially organ and/ or life threatening infection. Up to 90 of EPN occur in diabetic patients. The clinical course of EPN can be severe and life threatening if not recognized and treat promptly. Therefore it will be of value if EPN can be distinguished from APN on presentation. As EPN is a rare condition, knowledge about its demographic also has importance.

Comment added on 5/24/2017 9:48:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 9
Visits: 267
Title: Report on dialysis and kidney transplantation in Serbia 2011-2014. Compare to others
Authors: Simic Ogrizovic Sanja ,
Centre: Serbian society of nephrology

Poster most viewed in this topic
Poster: 175
Visits: 109
Title: ATYPICAL HEMOLYTIC UREMIC SYNDROME - VERY EARLY TREATMENT IS A WAY TO SUCCESS?
Authors: Vojtech Petr , Vojtech Petr1, Ivan Zahradka1, Karolina Kratka1, Monika Grussmannova1, Eva Honsova2, Ivan Rychlik1, 11st Dept. of Medicine, 3rd Faculty of Medicine, Charles University, Prague 2Institute of Clinical and Experimental Medicine, Dept. of Pathology, Prague
Centre: 1st Department of Medicine, 3rd Faculty of Medicine, Charles University


 




PosterSessionOnline
Logo Draft
 
Logo Cert